Rationale for Combining a Direct Renin Inhibitor with other Renin- Angiotensin System Blockers. Focus on Aliskiren and Combinations

Author： Siragy Helmy  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.25, Iss.1, 2011-02, pp. : 87-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Therapeutic Role of Renin-Angiotensin System Blockers in Obesity- Related Renal Disorders

By  

Current Clinical Pharmacology, Vol. 9, Iss. 1, 2014-01 ,pp. : 2-9

Bentham Science Publishers

Access to resources Recommend Favorite

Renin-angiotensin System Blockers and Modulation of Radiation-Induced Brain Injury

By  

Current Drug Targets, Vol. 11, Iss. 11, 2010-11 ,pp. : 1413-1422

Bentham Science Publishers

Access to resources Recommend Favorite

Combinations of Renin-Angiotensin-Aldosterone System Antagonists:True Advantages?

By  

Current Pharmaceutical Design, Vol. 18, Iss. 7, 2012-03 ,pp. : 952-957

Bentham Science Publishers

Access to resources Recommend Favorite

The Pulmonary Renin-Angiotensin System

By  

Current Pharmaceutical Design, Vol. 9, Iss. 9, 2003-04 ,pp. : 715-722

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the renin–angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

By Kjeldsen Sverre E   Lyle Paulette A   Tershakovec Andrew M   Devereux Richard B   Oparil Suzanne   Dahlöf Björn   de Faire Ulf   Fyhrquist Frej   Ibsen Hans   Kristianson Krister   Lederballe-Pedersen Ole   Lindholm Lars H   Nieminen Markku S   Omvik Per   Wedel Hans  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 729-745

Informa Healthcare

Access to resources Recommend Favorite